2) Since we have historically reported non-GAAP results to the investment
community, we believe the inclusion of non-GAAP numbers provides
consistency and enhances investors' ability to compare our performance
across financial reporting periods;
3) These non-GAAP financial measures are employed by Omnicell's management
in its own evaluation of performance and are utilized in financial and
operational decision making processes, such as budget planning and
forecasting; and
4) These non-GAAP financial measures facilitate comparisons to the
operating results of other companies in our industry, which use similar
financial measures to supplement their GAAP results, thus enhancing the
perspective of investors who wish to utilize such comparisons in their
analysis of our performance.
Set forth below are additional reasons why specific items are excluded
from our non-GAAP financial measures:
a) While stock-based compensation calculated in accordance with SFAS
No.123R constitutes an ongoing and recurring expense of Omnicell, it is
not an expense which requires cash settlement by Omnicell. We therefore
exclude these charges for purposes of evaluating core operating
results. Thus, our non-GAAP measurements are presented exclusive of
stock-based compensation expenses to assist management and investors in
evaluating our core operating results.
b) We present our reconciliation of non-GAAP financial measures on a net
of tax basis because the exact tax differences related to the timing
and deductibility of stock-based compensation, pursuant to the adoption
of SFAS No. 123R, is dependent upon the trading price of Omnicell's
common stock and the timing and exercise by employees of their stock
options. We analyze and measure operating results n
'/>"/>
| SOURCE Omnicell, Inc. Copyright©2008 PR Newswire. All rights reserved |